Results 191 to 200 of about 4,119,069 (249)

Acute Effects of Acarbose and Canagliflozin, Alone and in Combination, on Postprandial GLP‐1 and Glycaemic Responses in Post‐Bariatric Hypoglycaemia: A Randomised Crossover Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To evaluate the acute effects of acarbose and canagliflozin, alone and in combination, on postprandial total GLP‐1 and glycaemic responses during a mixed meal test in adults with post‐bariatric hypoglycaemia (PBH). Materials and Methods This single‐centre, randomised, four‐period crossover physiological study included 12 adults with PBH ...
Wei Yang   +11 more
wiley   +1 more source

Reduced Risk of MASLD and Cardiometabolic Disease Following Renal Denervation Therapy in Patients With Resistant Hypertension

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Autonomic dysfunction increases the risk of cardio‐kidney‐metabolic (CKM) syndrome including metabolic dysfunction‐associated steatotic liver disease (MASLD), type 2 diabetes (T2D), cardiovascular disease (CVD) and chronic kidney disease (CKD).
Alex E. Henney   +8 more
wiley   +1 more source

Early Testing of a Mobile App‐Based Intervention to Support Body Weight Awareness and Monitoring in Pregnancy: A Randomised Controlled Feasibility Trial (BUMP2.0)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To assess the feasibility of a mobile app‐based intervention to support gestational weight gain awareness and monitoring. Materials and Methods A total of 157 women aged ≥ 18 years, at < 20 weeks' gestation, were randomised 2:1 to an intervention (n = 107) or control group (n = 50), and followed‐up until late pregnancy (34 weeks ...
Moscho Michalopoulou   +5 more
wiley   +1 more source

GLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To critically examine the evolving evidence on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonist tirzepatide as adjuncts to insulin therapy in type 1 diabetes (T1D), with particular emphasis on their benefit–risk balance in individuals with ...
Thales Rossatto   +2 more
wiley   +1 more source

Developing a Method to Quantify Swelling Force Generated by the Osmotic Pump Tablet Push Layer. [PDF]

open access: yesPharmaceutics
Rogers TL   +5 more
europepmc   +1 more source

The Smart MDI System in People With Type 1 Diabetes and High HBA1C: A Randomized Controlled Trial Demonstrating That Response to Alerts Drives Outcomes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The aim was to assess the efficacy and safety of the smart multiple daily injections (MDI) system versus MDI plus continuous glucose monitor (CGM) in people with Type 1 diabetes and HbA1c ≥ 8%. Material and Methods After a 3‐week run‐in, 143 participants were randomized to Smart MDI or MDI + CGM.
Laurent Crenier   +21 more
wiley   +1 more source

Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles. [PDF]

open access: yesPharmaceutics
Ramirez JCR   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy